FeaturedAurobindo Pharma Clears US Antitrust Hurdle for $250 Million Lannett DealAurobindo Pharma wins FTC approval for its $250M Lannett acquisition, expanding its U.S. generics business and manufacturing base.Tara•Invalid Date